openPR Logo
Press release

Real World Evidence Solution Market worth $3.47 billion by 2030, growing at a CAGR of 14.09% - Exclusive Report by 360iResearch

03-12-2024 09:29 AM CET | Health & Medicine

Press release from: 360iResearch

Real World Evidence Solution Market | 360iResearch

Real World Evidence Solution Market | 360iResearch

The "Real World Evidence Solution Market by Component (Data Set, Services), Therapeutic Area (Cardiovascular, Immunology, Infectious Diseases), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Real World Evidence Solution Market to grow from USD 1.38 billion in 2023 to USD 3.47 billion by 2030, at a CAGR of 14.09%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/real-world-evidence-solution?utm_source=openpr&utm_medium=referral&utm_campaign=sample

The real world evidence (RWE) solutions enable healthcare organizations, government agencies, and pharmaceutical companies to analyze and utilize real-world data. This data, which includes information collected outside of traditional clinical trials such as electronic health records (EHR), insurance claims, patient registries, and mobile devices, is proving to be invaluable for understanding the effectiveness, safety, and value of healthcare interventions in day-to-day clinical practice. The rise in R&D by pharmaceutical companies has led to an increase in the adoption of RWE solutions for cost-effective drug development and shorter time-to-market. Regulatory bodies are increasingly acknowledging the value of RWE in understanding post-market drug and device usage, which encourages market growth. The growing healthcare industry's shift towards value-based care has promoted the use of RWE solutions to demonstrate the effectiveness of treatments. Data privacy & security concerns with real world evidence (RWE) solutions hampers the growth of the market. Developing advanced analytical models and algorithms to extract meaningful insights from diverse and large datasets and creating user-friendly platforms that accommodate complex needs are expected to create a platform for market growth.

In the Americas, the RWE solutions market is expanding with the growing healthcare reform initiatives that fuel demand to leverage RWE for enhanced decision-making. The Americas has seen a surge in patent filings related to advanced data analytics and AI in healthcare. Investment in digital health technologies continues to climb, reflecting the region's pursuit of innovation in healthcare delivery. In the European Union, the adoption of RWE solutions is heterogeneous, with some countries showing more advancement than others. The Euro-centric focus on cost-effectiveness and budget impact for healthcare interventions drives the demand for RWE. The Middle East and Africa showcase a diverse and emerging market for RWE solutions, where healthcare infrastructure and regulatory frameworks are developing at an uneven pace. The Asia Pacific region is a vibrant and fast-growing market for RWE solutions, with countries such as China, Japan, and India playing significant roles. China's latest five-year plan includes a substantial emphasis on healthcare and biotech, showcasing a commitment to invest in digital health and RWE generation. Japan's focus on healthcare innovation is evident in state-funded initiatives aimed at integrating RWE into healthcare delivery and pharmaceutical regulation. In India, increasing digitalization, government initiatives towards universal health coverage, and a growing pharmaceutical sector contribute to the RWE landscape.

Market Segmentation & Coverage:

This research report categorizes the Real World Evidence Solution Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Data Set and Services. The Data Set is further studied across Claims Data, Clinical Settings Data, Patient-Powered Data, and Pharmacy Data. The Data Set is projected to witness significant market share during forecast period.

Based on Therapeutic Area, market is studied across Cardiovascular, Immunology, Infectious Diseases, Neurology, and Oncology. The Oncology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biopharmaceutical Company, Clinical & Life Sciences Organization, and Diagnostics or Medical Device Company. The Diagnostics or Medical Device Company is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 36.40% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/real-world-evidence-solution?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Real World Evidence Solution Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Real World Evidence Solution Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Real World Evidence Solution Market, highlighting leading vendors and their innovative profiles. These include Aetion, Inc., Cardinal Health, Inc., Certara, L.P., Clinerion Ltd, Clinixir Company Limited, Cognizant Technology Solutions Corp., COREVITAS, LLC., Flatiron Health, Inc., ICON PLC, International Business Machines Corporation, IQVIA Inc., ISPOR, Laboratory Corporation of America Holdings, Mercy Technology Services, Optum, Inc., Oracle Corporation, PAREXEL International Corporation, PerkinElmer Inc., Pharmaceutical Product Development, LLC by Thermo Fisher Scientific Inc., Quantzig, SAS Institute, Inc., Syneos Health, TATA Consultancy Services Limited, Turacoz, and United BioSource LLC.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Real World Evidence Solution Market, by Component
7. Real World Evidence Solution Market, by Therapeutic Area
8. Real World Evidence Solution Market, by End-User
9. Americas Real World Evidence Solution Market
10. Asia-Pacific Real World Evidence Solution Market
11. Europe, Middle East & Africa Real World Evidence Solution Market
12. Competitive Landscape
13. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Real World Evidence Solution Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Real World Evidence Solution Market?
3. What is the competitive strategic window for opportunities in the Real World Evidence Solution Market?
4. What are the technology trends and regulatory frameworks in the Real World Evidence Solution Market?
5. What is the market share of the leading vendors in the Real World Evidence Solution Market?
6. What modes and strategic moves are considered suitable for entering the Real World Evidence Solution Market?

Read More @ https://www.360iresearch.com/library/intelligence/real-world-evidence-solution?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Real World Evidence Solution Market worth $3.47 billion by 2030, growing at a CAGR of 14.09% - Exclusive Report by 360iResearch here

News-ID: 3424441 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Solution

EVCC/SECC, EVCC Overall Solution, SECC Overall Solution
What is secc EV? Supply Equipment Communication Controller. Our Supply Equipment Communication Controller (SECC) acts as the main controller for the charging process. What is a SECC [https://www.midapower.com/]? SECC may refer to: Single Edge Contact Cartridge, a connector for microprocessors. SECC (metal), a low-cost sheet metal often used for computer cases. Scottish Exhibition and Conference Centre, now known as the SEC Centre, an exhibition space in Glasgow, Scotland. This is full functional
Call Center Solution for your business call solution
Elevate Your Customer Service with Our Comprehensive Suite of Call Center Solution and Services. Start your customer success journey with the help of ConVox Call Center Solution. In today's competitive landscape, delivering exceptional customer service is essential. Traditional call centers often struggle with long wait times and overwhelmed agents. This impacts your brand image and bottom line. ConVox Call Center Solution provides the tools needed to transform your call center operations.
CompanyTRAK Launches Enterprise Solution, a Contact Tracing, Social Distancing S …
Sqwirrel LLC, a Michigan company, has developed patent-pending technology utilizing a combination of enterprise mobile apps, with Bluetooth tags and scanners to bring employees back to their workplace called "CompanyTRAK". The contact tracing technology and social distancing solution provides a safe way to get employees back to work, keep them mindful of social distancing and alert them to possible risks of exposure from symptomatic, positive tested and exposed employees. CompanyTRAK
Robotic Process Automation (RPA) Market Insights, Forecast to 2025: By Types - A …
Marketresearchreports.biz Announced New Study on Report "Global Robotic Process Automation (RPA) Market Insights, Forecast to 2025." This report presents the worldwide Robotic Process Automation (RPA) market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors
Euroweb swaps existing Class 4 solution for TELES softswitch solution
Euroweb, one of Romania's leading service providers, has decided to ditch its legacy multi-vendor solution and replace it with a unified wholesale solution based on the C4 Softswitch from the Berlin based Next Generation Networks and Access Gateway vendor TELES. Identifying TELES as a vendor for the required solution, Euroweb Romania selected TELES C4 softswitch in addition to the TELES Captura WTP (Wholesale Trading Platform), which makes life easier for operators
RI-Solution GmbH Selects SAP Nearline Solution from SAND
SAND/DNA for SAP BI to be used by major German retailer Hamburg, April 25, 2006 – RI-Solution GmbH, a Munich-based IT service provider specializing in information systems, services and solutions for retail companies, has licensed SAND/DNA in conjunction with SAP NetWeaver BI 3.5 to meet the needs of a major retail client. The SAND solution, officially certified by SAP as an integrated ABAP add-on with SAP NetWeaver® Business Intelligence (SAP NetWeaver®